For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...

For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention. This approach limits the ...

Coronary artery disease (CAD) continues to be a leading cause of morbidity and mortality globally. The recommendations that ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

Experts discuss atherosclerotic cardiovascular disease and aortic stenosis, as well as their burden, highlighting their prevalence, impact on patient health, and the growing need for effective ...

Coffee filters reduce intake of LDL cholesterol-generating compounds found in the brew and subsequently may lower risk for ...

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among ...

A recent study highlights the effectiveness of Semaglutide, an anti-diabetes drug, in reducing the risk of heart attacks and ...

Semaglutide can help lower the risk of cardiovascular complications in people with diabetes, a new study has found.

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...